Author

Ahmet Cingöz

Bezmiâlem Vakıf ÜniversitesiORCID 0000-0002-1111-7752Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Assay:bulk RNA-seq· 2 Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Approach:genetic perturbation / CRISPR· 2 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Assay:imaging· 1

Frequent Co-Authors

Adam P. CribbsiD· 2 shared Ali Cenk AksuiD· 2 shared Ebru YilmaziD· 2 shared Hamzah SyediD· 2 shared Martin PhilpottiD· 2 shared Ozlem Yedier-BayramiD· 2 shared Tugba Bagci OnderiD· 2 shared Altar OzbıyıkiD· 1 shared

Activity by Year

2024-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 35 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Adam P. CribbsORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Coupling Raman Spectroscopy and Acoustic Microscopy to Characterize Glioblastoma Resistance

Tuna Pesen, Arda Inanç, Demet Inci, Ahmet Cingöz, B. Akgün

This study uses Raman spectroscopy and acoustic microscopy to identify biophysical markers of glioblastoma resistance, finding distinct biochemical and mechanical differences between resistant and sensitive cells.

bioRxiv · Oct 16, 2026 · PreprintBiophysics

Functional Genomic Screens Reveal RBBP4 as a Key Regulator of Cell Cycle Progression in TMZ-Resistant Glioblastoma

Ezgi Yağmur Kala, Filiz Senbabaoglu Aksu, Muhammed Erdem Ercan, Altar Ozbıyık, Ahmet Cingöz, Ozlem Yedier-Bayram, Ali Cenk Aksu, Ayşe Derya Cavga, Ebru Yilmaz, İpek Kok, Ayşe Hümeyra Dur Karasayar, İbrahim Kulaç, Hamzah Syed, Martin Philpott, Adam P. Cribbs, Tugba Bagci Onder

This study identifies RBBP4 as a critical regulator of cell cycle progression in TMZ-resistant glioblastoma through CRISPR screens and functional analyses.

bioRxiv · May 9, 2025 · PreprintCancer Biology

Chromatin-focused genetic and chemical screens identify BRPF1 as a targetable vulnerability in Taxol-resistant triple-negative breast cancer

Ozlem Yedier-Bayram, Ahmet Cingöz, Ebru Yilmaz, Ali Cenk Aksu, Beril Esin, N. Pinarbasi Degirmenci, Ayse Derya Cavga, Beyza Dedeoğlu, Buse Cevatemre, Hamzah Syed, Martin Philpott, Adam P. Cribbs, Udo Oppermann, Nathan A. Lack, Ceyda Acilan, , Tugba Bagci-Onder

The paper identifies BRPF1 as a key regulator of Taxol resistance in TNBC through genetic and chemical screens, showing its inhibition sensitizes resistant cells to chemotherapy.

bioRxiv · Apr 16, 2024Cancer Biology